Cargando…
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
We report that combination bNAb immunotherapy initiated on day 3 post-infection (PI) maintained durable CD8(+) T cell–mediated suppression of SHIV(AD8) viremia and preinoculation levels of CD4(+) T cells in 9 of 13 treated monkeys during nearly 6 yr of observation, as assessed by successive CD8(+) T...
Autores principales: | Nishimura, Yoshiaki, Donau, Olivia K., Dias, Joana, Ferrando-Martinez, Sara, Jesteadt, Eric, Sadjadpour, Reza, Gautam, Rajeev, Buckler-White, Alicia, Geleziunas, Romas, Koup, Richard A., Nussenzweig, Michel C., Martin, Malcolm A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7953630/ https://www.ncbi.nlm.nih.gov/pubmed/32966579 http://dx.doi.org/10.1084/jem.20201214 |
Ejemplares similares
-
Prevention and treatment of SHIVAD8 infection in rhesus macaques by a potent d-peptide HIV entry inhibitor
por: Nishimura, Yoshiaki, et al.
Publicado: (2020) -
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
por: Shingai, Masashi, et al.
Publicado: (2014) -
A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection
por: Gautam, Rajeev, et al.
Publicado: (2018) -
Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques
por: Ng, Cherie T., et al.
Publicado: (2010) -
Therapeutic vaccination with IDLV-SIV-Gag results in durable viremia control in chronically SHIV-infected macaques
por: Blasi, Maria, et al.
Publicado: (2020)